#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=An abdominal aortic aneurysm ( AAA ) is a localized irreversible dilatation of the abdominal segment of the aorta , often due to a weakening of the wall of the vessel .
2-1	16-18	An	organization[3]	new[3]	appos	2-6[0_3]
2-2	19-28	abdominal	organization[3]	new[3]	_	_
2-3	29-35	aortic	abstract|organization[3]	new|new[3]	coref	2-18[7_0]
2-4	36-44	aneurysm	organization[3]	new[3]	_	_
2-5	45-46	(	_	_	_	_
2-6	47-50	AAA	organization	giv	coref	2-9[5_0]
2-7	51-52	)	_	_	_	_
2-8	53-55	is	_	_	_	_
2-9	56-57	a	organization[5]	giv[5]	coref	3-1[11_5]
2-10	58-67	localized	organization[5]	giv[5]	_	_
2-11	68-80	irreversible	organization[5]	giv[5]	_	_
2-12	81-91	dilatation	organization[5]	giv[5]	_	_
2-13	92-94	of	organization[5]	giv[5]	_	_
2-14	95-98	the	organization[5]|place[6]	giv[5]|new[6]	_	_
2-15	99-108	abdominal	organization[5]|place[6]	giv[5]|new[6]	_	_
2-16	109-116	segment	organization[5]|place[6]	giv[5]|new[6]	_	_
2-17	117-119	of	organization[5]|place[6]	giv[5]|new[6]	_	_
2-18	120-123	the	organization[5]|place[6]|abstract[7]	giv[5]|new[6]|giv[7]	coref	4-6[18_7]
2-19	124-129	aorta	organization[5]|place[6]|abstract[7]	giv[5]|new[6]|giv[7]	_	_
2-20	130-131	,	_	_	_	_
2-21	132-137	often	_	_	_	_
2-22	138-141	due	_	_	_	_
2-23	142-144	to	_	_	_	_
2-24	145-146	a	event[8]	new[8]	_	_
2-25	147-156	weakening	event[8]	new[8]	_	_
2-26	157-159	of	event[8]	new[8]	_	_
2-27	160-163	the	event[8]|object[9]	new[8]|new[9]	coref	10-14[0_9]
2-28	164-168	wall	event[8]|object[9]	new[8]|new[9]	_	_
2-29	169-171	of	event[8]|object[9]	new[8]|new[9]	_	_
2-30	172-175	the	event[8]|object[9]|object[10]	new[8]|new[9]|new[10]	coref	5-55[0_10]
2-31	176-182	vessel	event[8]|object[9]|object[10]	new[8]|new[9]|new[10]	_	_
2-32	183-184	.	_	_	_	_

#Text=An AAA refers to a diameter increase of at least 50 % compared to the normal arteria , which measures indicatively 2 cm .
3-1	185-187	An	organization[11]	giv[11]	coref	4-23[22_11]
3-2	188-191	AAA	organization[11]	giv[11]	_	_
3-3	192-198	refers	_	_	_	_
3-4	199-201	to	_	_	_	_
3-5	202-203	a	abstract[13]	new[13]	_	_
3-6	204-212	diameter	abstract|abstract[13]	new|new[13]	coref	4-11[19_0]
3-7	213-221	increase	abstract[13]	new[13]	_	_
3-8	222-224	of	abstract[13]	new[13]	_	_
3-9	225-227	at	abstract[13]|quantity[14]	new[13]|new[14]	_	_
3-10	228-233	least	abstract[13]|quantity[14]	new[13]|new[14]	_	_
3-11	234-236	50	abstract[13]|quantity[14]	new[13]|new[14]	_	_
3-12	237-238	%	abstract[13]|quantity[14]	new[13]|new[14]	_	_
3-13	239-247	compared	_	_	_	_
3-14	248-250	to	_	_	_	_
3-15	251-254	the	abstract[15]	new[15]	_	_
3-16	255-261	normal	abstract[15]	new[15]	_	_
3-17	262-269	arteria	abstract[15]	new[15]	_	_
3-18	270-271	,	_	_	_	_
3-19	272-277	which	_	_	_	_
3-20	278-286	measures	_	_	_	_
3-21	287-299	indicatively	quantity[16]	new[16]	_	_
3-22	300-301	2	quantity[16]	new[16]	_	_
3-23	302-304	cm	quantity[16]	new[16]	_	_
3-24	305-306	.	_	_	_	_

#Text=Thus , a segment of the abdominal aorta in which the diameter is equal or greater than 3.0 cm is generally considered an aortic aneurysm .
4-1	307-311	Thus	_	_	_	_
4-2	312-313	,	_	_	_	_
4-3	314-315	a	object[17]	new[17]	_	_
4-4	316-323	segment	object[17]	new[17]	_	_
4-5	324-326	of	object[17]	new[17]	_	_
4-6	327-330	the	object[17]|abstract[18]	new[17]|giv[18]	coref	4-24[0_18]
4-7	331-340	abdominal	object[17]|abstract[18]	new[17]|giv[18]	_	_
4-8	341-346	aorta	object[17]|abstract[18]	new[17]|giv[18]	_	_
4-9	347-349	in	_	_	_	_
4-10	350-355	which	_	_	_	_
4-11	356-359	the	abstract[19]	giv[19]	coref	7-45[71_19]
4-12	360-368	diameter	abstract[19]	giv[19]	_	_
4-13	369-371	is	_	_	_	_
4-14	372-377	equal	_	_	_	_
4-15	378-380	or	_	_	_	_
4-16	381-388	greater	_	_	_	_
4-17	389-393	than	_	_	_	_
4-18	394-397	3.0	quantity[20]	new[20]	_	_
4-19	398-400	cm	quantity[20]	new[20]	_	_
4-20	401-403	is	_	_	_	_
4-21	404-413	generally	_	_	_	_
4-22	414-424	considered	_	_	_	_
4-23	425-427	an	organization[22]	giv[22]	coref	5-6[0_22]
4-24	428-434	aortic	abstract|organization[22]	giv|giv[22]	coref	19-12
4-25	435-443	aneurysm	organization[22]	giv[22]	_	_
4-26	444-445	.	_	_	_	_

#Text=In developed countries , an AAA rupture represents an important cause of death with a mortality rate of approximatively 80 – 90 % ; several risk factors are associated with the development of AAA including advanced age , male sex , Caucasian race , positive family history , smoking , presence of other large vessel aneurysms , and atherosclerosis .
5-1	446-448	In	_	_	_	_
5-2	449-458	developed	place[23]	new[23]	_	_
5-3	459-468	countries	place[23]	new[23]	_	_
5-4	469-470	,	_	_	_	_
5-5	471-473	an	event[25]	new[25]	coref	7-16[0_25]
5-6	474-477	AAA	organization|event[25]	giv|new[25]	coref	5-34
5-7	478-485	rupture	event[25]	new[25]	_	_
5-8	486-496	represents	_	_	_	_
5-9	497-499	an	abstract[26]	new[26]	_	_
5-10	500-509	important	abstract[26]	new[26]	_	_
5-11	510-515	cause	abstract[26]	new[26]	_	_
5-12	516-518	of	abstract[26]	new[26]	_	_
5-13	519-524	death	abstract[26]|event	new[26]|new	_	_
5-14	525-529	with	abstract[26]	new[26]	_	_
5-15	530-531	a	abstract[26]|abstract[29]	new[26]|new[29]	_	_
5-16	532-541	mortality	abstract[26]|abstract|abstract[29]	new[26]|new|new[29]	_	_
5-17	542-546	rate	abstract[26]|abstract[29]	new[26]|new[29]	_	_
5-18	547-549	of	abstract[26]|abstract[29]	new[26]|new[29]	_	_
5-19	550-565	approximatively	abstract[26]|abstract[29]|quantity[31]	new[26]|new[29]|new[31]	_	_
5-20	566-568	80	abstract[26]|abstract[29]|quantity[31]	new[26]|new[29]|new[31]	_	_
5-21	569-570	–	abstract[26]|abstract[29]|quantity[31]	new[26]|new[29]|new[31]	_	_
5-22	571-573	90	abstract[26]|abstract[29]|quantity|quantity[31]	new[26]|new[29]|new|new[31]	_	_
5-23	574-575	%	abstract[26]|abstract[29]|quantity[31]	new[26]|new[29]|new[31]	_	_
5-24	576-577	;	_	_	_	_
5-25	578-585	several	abstract[33]	new[33]	coref	6-32[51_33]
5-26	586-590	risk	abstract|abstract[33]	new|new[33]	coref	7-30[66_0]
5-27	591-598	factors	abstract[33]	new[33]	_	_
5-28	599-602	are	_	_	_	_
5-29	603-613	associated	_	_	_	_
5-30	614-618	with	_	_	_	_
5-31	619-622	the	abstract[34]	new[34]	_	_
5-32	623-634	development	abstract[34]	new[34]	_	_
5-33	635-637	of	abstract[34]	new[34]	_	_
5-34	638-641	AAA	abstract[34]|organization	new[34]|giv	coref	6-42[54_0]
5-35	642-651	including	abstract[34]	new[34]	_	_
5-36	652-660	advanced	abstract[34]|abstract[36]	new[34]|new[36]	_	_
5-37	661-664	age	abstract[34]|abstract[36]	new[34]|new[36]	_	_
5-38	665-666	,	abstract[34]	new[34]	_	_
5-39	667-671	male	abstract[34]|abstract[37]	new[34]|new[37]	_	_
5-40	672-675	sex	abstract[34]|abstract[37]	new[34]|new[37]	_	_
5-41	676-677	,	abstract[34]	new[34]	_	_
5-42	678-687	Caucasian	abstract[34]|abstract[38]	new[34]|new[38]	_	_
5-43	688-692	race	abstract[34]|abstract[38]	new[34]|new[38]	_	_
5-44	693-694	,	abstract[34]	new[34]	_	_
5-45	695-703	positive	abstract[34]|abstract[40]	new[34]|new[40]	_	_
5-46	704-710	family	abstract[34]|abstract|abstract[40]	new[34]|new|new[40]	_	_
5-47	711-718	history	abstract[34]|abstract[40]	new[34]|new[40]	_	_
5-48	719-720	,	abstract[34]	new[34]	_	_
5-49	721-728	smoking	abstract[34]	new[34]	_	_
5-50	729-730	,	abstract[34]	new[34]	_	_
5-51	731-739	presence	abstract[34]|abstract[41]	new[34]|new[41]	_	_
5-52	740-742	of	abstract[34]|abstract[41]	new[34]|new[41]	_	_
5-53	743-748	other	abstract[34]|abstract[41]|object[43]	new[34]|new[41]|new[43]	_	_
5-54	749-754	large	abstract[34]|abstract[41]|object[43]	new[34]|new[41]|new[43]	_	_
5-55	755-761	vessel	abstract[34]|abstract[41]|object|object[43]	new[34]|new[41]|giv|new[43]	coref	17-32[190_0]
5-56	762-771	aneurysms	abstract[34]|abstract[41]|object[43]	new[34]|new[41]|new[43]	_	_
5-57	772-773	,	abstract[34]	new[34]	_	_
5-58	774-777	and	abstract[34]	new[34]	_	_
5-59	778-793	atherosclerosis	abstract[34]|abstract	new[34]|new	_	_
5-60	794-795	.	_	_	_	_

#Text=Despite the clinical importance of AAAs , the etiology and the involved pathogenesis remain still , in part , unclear ; it is , then , evident how the identification of the factors that can influence the growth and progression of the aneurysm is fundamental for Public Health management .
6-1	796-803	Despite	_	_	_	_
6-2	804-807	the	abstract[45]	new[45]	_	_
6-3	808-816	clinical	abstract[45]	new[45]	_	_
6-4	817-827	importance	abstract[45]	new[45]	_	_
6-5	828-830	of	abstract[45]	new[45]	_	_
6-6	831-835	AAAs	abstract[45]|object	new[45]|new	coref	8-14
6-7	836-837	,	_	_	_	_
6-8	838-841	the	abstract[47]	new[47]	_	_
6-9	842-850	etiology	abstract[47]	new[47]	_	_
6-10	851-854	and	_	_	_	_
6-11	855-858	the	abstract[48]	new[48]	ana	6-22[0_48]
6-12	859-867	involved	abstract[48]	new[48]	_	_
6-13	868-880	pathogenesis	abstract[48]	new[48]	_	_
6-14	881-887	remain	_	_	_	_
6-15	888-893	still	_	_	_	_
6-16	894-895	,	_	_	_	_
6-17	896-898	in	_	_	_	_
6-18	899-903	part	_	_	_	_
6-19	904-905	,	_	_	_	_
6-20	906-913	unclear	_	_	_	_
6-21	914-915	;	_	_	_	_
6-22	916-918	it	abstract	giv	_	_
6-23	919-921	is	_	_	_	_
6-24	922-923	,	_	_	_	_
6-25	924-928	then	_	_	_	_
6-26	929-930	,	_	_	_	_
6-27	931-938	evident	_	_	_	_
6-28	939-942	how	_	_	_	_
6-29	943-946	the	abstract[50]	new[50]	_	_
6-30	947-961	identification	abstract[50]	new[50]	_	_
6-31	962-964	of	abstract[50]	new[50]	_	_
6-32	965-968	the	abstract[50]|abstract[51]	new[50]|giv[51]	coref	9-28[89_51]
6-33	969-976	factors	abstract[50]|abstract[51]	new[50]|giv[51]	_	_
6-34	977-981	that	_	_	_	_
6-35	982-985	can	_	_	_	_
6-36	986-995	influence	_	_	_	_
6-37	996-999	the	abstract[52]	new[52]	_	_
6-38	1000-1006	growth	abstract[52]	new[52]	_	_
6-39	1007-1010	and	_	_	_	_
6-40	1011-1022	progression	abstract[53]	new[53]	_	_
6-41	1023-1025	of	abstract[53]	new[53]	_	_
6-42	1026-1029	the	abstract[53]|organization[54]	new[53]|giv[54]	coref	7-7[59_54]
6-43	1030-1038	aneurysm	abstract[53]|organization[54]	new[53]|giv[54]	_	_
6-44	1039-1041	is	_	_	_	_
6-45	1042-1053	fundamental	_	_	_	_
6-46	1054-1057	for	_	_	_	_
6-47	1058-1064	Public	abstract[55]|abstract[56]	new[55]|new[56]	_	_
6-48	1065-1071	Health	abstract[55]|abstract[56]	new[55]|new[56]	_	_
6-49	1072-1082	management	abstract[56]	new[56]	_	_
6-50	1083-1084	.	_	_	_	_

#Text=For asymptomatic patients , repair of the aneurysm is the most effective treatment to prevent rupture but considering the risks associated with surgery , AAA repair is recommended if the risk of rupture exceeds the risks associated with surgery , which typically occurs when the AAA diameter exceeds 5.5 cm .
7-1	1085-1088	For	_	_	_	_
7-2	1089-1101	asymptomatic	person[57]	new[57]	_	_
7-3	1102-1110	patients	person[57]	new[57]	_	_
7-4	1111-1112	,	_	_	_	_
7-5	1113-1119	repair	abstract[58]	new[58]	coref	7-10[60_58]
7-6	1120-1122	of	abstract[58]	new[58]	_	_
7-7	1123-1126	the	abstract[58]|organization[59]	new[58]|giv[59]	coref	7-25[0_59]
7-8	1127-1135	aneurysm	abstract[58]|organization[59]	new[58]|giv[59]	_	_
7-9	1136-1138	is	_	_	_	_
7-10	1139-1142	the	abstract[60]	giv[60]	coref	7-25[65_60]
7-11	1143-1147	most	abstract[60]	giv[60]	_	_
7-12	1148-1157	effective	abstract[60]	giv[60]	_	_
7-13	1158-1167	treatment	abstract[60]	giv[60]	_	_
7-14	1168-1170	to	_	_	_	_
7-15	1171-1178	prevent	_	_	_	_
7-16	1179-1186	rupture	event	giv	coref	7-33
7-17	1187-1190	but	_	_	_	_
7-18	1191-1202	considering	_	_	_	_
7-19	1203-1206	the	quantity[62]	new[62]	coref	7-35[68_62]
7-20	1207-1212	risks	quantity[62]	new[62]	_	_
7-21	1213-1223	associated	_	_	_	_
7-22	1224-1228	with	_	_	_	_
7-23	1229-1236	surgery	event	new	coref	7-39
7-24	1237-1238	,	_	_	_	_
7-25	1239-1242	AAA	organization|abstract[65]	giv|giv[65]	coref|coref	7-46|7-46
7-26	1243-1249	repair	abstract[65]	giv[65]	_	_
7-27	1250-1252	is	_	_	_	_
7-28	1253-1264	recommended	_	_	_	_
7-29	1265-1267	if	_	_	_	_
7-30	1268-1271	the	abstract[66]	giv[66]	coref	9-29[0_66]
7-31	1272-1276	risk	abstract[66]	giv[66]	_	_
7-32	1277-1279	of	abstract[66]	giv[66]	_	_
7-33	1280-1287	rupture	abstract[66]|event	giv[66]|giv	coref	8-9
7-34	1288-1295	exceeds	_	_	_	_
7-35	1296-1299	the	abstract[68]	giv[68]	_	_
7-36	1300-1305	risks	abstract[68]	giv[68]	_	_
7-37	1306-1316	associated	_	_	_	_
7-38	1317-1321	with	_	_	_	_
7-39	1322-1329	surgery	event	giv	_	_
7-40	1330-1331	,	_	_	_	_
7-41	1332-1337	which	_	_	_	_
7-42	1338-1347	typically	_	_	_	_
7-43	1348-1354	occurs	_	_	_	_
7-44	1355-1359	when	_	_	_	_
7-45	1360-1363	the	abstract[71]	giv[71]	coref	8-2[74_71]
7-46	1364-1367	AAA	organization|abstract[71]	giv|giv[71]	coref	8-2
7-47	1368-1376	diameter	abstract[71]	giv[71]	_	_
7-48	1377-1384	exceeds	_	_	_	_
7-49	1385-1388	5.5	quantity[72]	new[72]	_	_
7-50	1389-1391	cm	quantity[72]	new[72]	_	_
7-51	1392-1393	.	_	_	_	_

#Text=Although AAA diameter is an important predictor of rupture , not all large AAAs break , it is then fundamental to look at this phenomenon in a more complex framework .
8-1	1394-1402	Although	_	_	_	_
8-2	1403-1406	AAA	organization|abstract[74]	giv|giv[74]	coref|coref|coref|coref	8-5[75_74]|11-27|8-5[75_74]|11-27
8-3	1407-1415	diameter	abstract[74]	giv[74]	_	_
8-4	1416-1418	is	_	_	_	_
8-5	1419-1421	an	abstract[75]	giv[75]	coref	11-25[116_75]
8-6	1422-1431	important	abstract[75]	giv[75]	_	_
8-7	1432-1441	predictor	abstract[75]	giv[75]	_	_
8-8	1442-1444	of	abstract[75]	giv[75]	_	_
8-9	1445-1452	rupture	abstract[75]|event	giv[75]|giv	coref	11-11
8-10	1453-1454	,	abstract[75]	giv[75]	_	_
8-11	1455-1458	not	abstract[75]	giv[75]	_	_
8-12	1459-1462	all	abstract[75]|event[78]	giv[75]|new[78]	_	_
8-13	1463-1468	large	abstract[75]|event[78]	giv[75]|new[78]	_	_
8-14	1469-1473	AAAs	abstract[75]|abstract|event[78]	giv[75]|giv|new[78]	coref	9-23
8-15	1474-1479	break	abstract[75]|event[78]	giv[75]|new[78]	_	_
8-16	1480-1481	,	_	_	_	_
8-17	1482-1484	it	abstract	new	cata	8-17[0_80]
8-18	1485-1487	is	_	_	_	_
8-19	1488-1492	then	_	_	_	_
8-20	1493-1504	fundamental	_	_	_	_
8-21	1505-1507	to	abstract[80]	new[80]	_	_
8-22	1508-1512	look	abstract[80]	new[80]	_	_
8-23	1513-1515	at	_	_	_	_
8-24	1516-1520	this	abstract[81]	new[81]	_	_
8-25	1521-1531	phenomenon	abstract[81]	new[81]	_	_
8-26	1532-1534	in	_	_	_	_
8-27	1535-1536	a	abstract[82]	new[82]	_	_
8-28	1537-1541	more	abstract[82]	new[82]	_	_
8-29	1542-1549	complex	abstract[82]	new[82]	_	_
8-30	1550-1559	framework	abstract[82]	new[82]	_	_
8-31	1560-1561	.	_	_	_	_

#Text=To this aim , clinical , experimental , and numerical studies are being widely performed , focusing on the deep investigation of AAAs and the determination of possible risk factors , as well as on reproducing their hemodynamics .
9-1	1562-1564	To	_	_	_	_
9-2	1565-1569	this	abstract[83]	new[83]	coref	22-19[236_83]
9-3	1570-1573	aim	abstract[83]	new[83]	_	_
9-4	1574-1575	,	_	_	_	_
9-5	1576-1584	clinical	abstract[84]	new[84]	_	_
9-6	1585-1586	,	abstract[84]	new[84]	_	_
9-7	1587-1599	experimental	abstract[84]	new[84]	_	_
9-8	1600-1601	,	abstract[84]	new[84]	_	_
9-9	1602-1605	and	abstract[84]	new[84]	_	_
9-10	1606-1615	numerical	abstract[84]	new[84]	_	_
9-11	1616-1623	studies	abstract[84]	new[84]	_	_
9-12	1624-1627	are	_	_	_	_
9-13	1628-1633	being	_	_	_	_
9-14	1634-1640	widely	_	_	_	_
9-15	1641-1650	performed	_	_	_	_
9-16	1651-1652	,	_	_	_	_
9-17	1653-1661	focusing	_	_	_	_
9-18	1662-1664	on	_	_	_	_
9-19	1665-1668	the	abstract[85]	new[85]	_	_
9-20	1669-1673	deep	abstract[85]	new[85]	_	_
9-21	1674-1687	investigation	abstract[85]	new[85]	_	_
9-22	1688-1690	of	abstract[85]	new[85]	_	_
9-23	1691-1695	AAAs	abstract[85]|object	new[85]|giv	coref	20-11[213_0]
9-24	1696-1699	and	_	_	_	_
9-25	1700-1703	the	abstract[87]	new[87]	_	_
9-26	1704-1717	determination	abstract[87]	new[87]	_	_
9-27	1718-1720	of	abstract[87]	new[87]	_	_
9-28	1721-1729	possible	abstract[87]|abstract[89]	new[87]|giv[89]	ana	9-37[0_89]
9-29	1730-1734	risk	abstract[87]|abstract|abstract[89]	new[87]|giv|giv[89]	coref	11-8[111_0]
9-30	1735-1742	factors	abstract[87]|abstract[89]	new[87]|giv[89]	_	_
9-31	1743-1744	,	_	_	_	_
9-32	1745-1747	as	_	_	_	_
9-33	1748-1752	well	_	_	_	_
9-34	1753-1755	as	_	_	_	_
9-35	1756-1758	on	_	_	_	_
9-36	1759-1770	reproducing	_	_	_	_
9-37	1771-1776	their	abstract|abstract[91]	giv|new[91]	coref|coref|coref|coref	10-3[92_91]|21-26[230_0]|10-3[92_91]|21-26[230_0]
9-38	1777-1789	hemodynamics	abstract[91]	new[91]	_	_
9-39	1790-1791	.	_	_	_	_

#Text=Usually , the local hemodynamics is quantified in terms of the distributions of wall pressure , wall shear stress ( WSS ) , and wall shear stress gradient ( WSSG ) .
10-1	1792-1799	Usually	_	_	_	_
10-2	1800-1801	,	_	_	_	_
10-3	1802-1805	the	abstract[92]	giv[92]	coref	26-15[0_92]
10-4	1806-1811	local	abstract[92]	giv[92]	_	_
10-5	1812-1824	hemodynamics	abstract[92]	giv[92]	_	_
10-6	1825-1827	is	_	_	_	_
10-7	1828-1838	quantified	_	_	_	_
10-8	1839-1841	in	_	_	_	_
10-9	1842-1847	terms	_	_	_	_
10-10	1848-1850	of	_	_	_	_
10-11	1851-1854	the	abstract[93]	new[93]	_	_
10-12	1855-1868	distributions	abstract[93]	new[93]	_	_
10-13	1869-1871	of	abstract[93]	new[93]	_	_
10-14	1872-1876	wall	abstract[93]|object|abstract[95]	new[93]|giv|new[95]	coref|coref|coref|coref	10-17|14-52[141_95]|10-17|14-52[141_95]
10-15	1877-1885	pressure	abstract[93]|abstract[95]	new[93]|new[95]	_	_
10-16	1886-1887	,	abstract[93]	new[93]	_	_
10-17	1888-1892	wall	abstract[93]|object|abstract[98]	new[93]|giv|new[98]	appos|coref|appos|coref	10-21[0_98]|10-25|10-21[0_98]|10-25
10-18	1893-1898	shear	abstract[93]|place|abstract[98]	new[93]|new|new[98]	coref	10-26
10-19	1899-1905	stress	abstract[93]|abstract[98]	new[93]|new[98]	_	_
10-20	1906-1907	(	abstract[93]	new[93]	_	_
10-21	1908-1911	WSS	abstract[93]|abstract	new[93]|giv	coref	10-27
10-22	1912-1913	)	abstract[93]	new[93]	_	_
10-23	1914-1915	,	abstract[93]	new[93]	_	_
10-24	1916-1919	and	abstract[93]	new[93]	_	_
10-25	1920-1924	wall	abstract[93]|object|abstract[103]	new[93]|giv|new[103]	appos|coref|appos|coref	10-30[0_103]|11-10|10-30[0_103]|11-10
10-26	1925-1930	shear	abstract[93]|abstract|abstract[103]	new[93]|giv|new[103]	coref	14-56
10-27	1931-1937	stress	abstract[93]|abstract|abstract[103]	new[93]|giv|new[103]	coref	11-1[106_0]
10-28	1938-1946	gradient	abstract[93]|abstract[103]	new[93]|new[103]	_	_
10-29	1947-1948	(	_	_	_	_
10-30	1949-1953	WSSG	abstract	giv	coref	14-62[149_0]
10-31	1954-1955	)	_	_	_	_
10-32	1956-1957	.	_	_	_	_

#Text=The peak WSS ( PWSS ) and the peak wall rupture risk ( PWRR ) have proved to be better predictors of rupture than the maximum AAA diameter ( [ 7 ] and reference therein , ) .
11-1	1958-1961	The	abstract[106]	giv[106]	appos	11-5[0_106]
11-2	1962-1966	peak	abstract|abstract[106]	new|giv[106]	coref	11-9
11-3	1967-1970	WSS	abstract[106]	giv[106]	_	_
11-4	1971-1972	(	_	_	_	_
11-5	1973-1977	PWSS	abstract	giv	coref	14-55[144_0]
11-6	1978-1979	)	_	_	_	_
11-7	1980-1983	and	_	_	_	_
11-8	1984-1987	the	abstract[111]	giv[111]	appos	11-14[0_111]
11-9	1988-1992	peak	abstract|abstract[111]	giv|giv[111]	_	_
11-10	1993-1997	wall	object|abstract[111]	giv|giv[111]	coref	14-52
11-11	1998-2005	rupture	event|abstract[111]	giv|giv[111]	coref	11-23[114_0]
11-12	2006-2010	risk	abstract[111]	giv[111]	_	_
11-13	2011-2012	(	_	_	_	_
11-14	2013-2017	PWRR	abstract	giv	coref	17-16[186_0]
11-15	2018-2019	)	_	_	_	_
11-16	2020-2024	have	_	_	_	_
11-17	2025-2031	proved	_	_	_	_
11-18	2032-2034	to	_	_	_	_
11-19	2035-2037	be	_	_	_	_
11-20	2038-2044	better	abstract[113]	new[113]	_	_
11-21	2045-2055	predictors	abstract[113]	new[113]	_	_
11-22	2056-2058	of	abstract[113]	new[113]	_	_
11-23	2059-2066	rupture	abstract[113]|event[114]	new[113]|giv[114]	coref	17-18[0_114]
11-24	2067-2071	than	abstract[113]|event[114]	new[113]|giv[114]	_	_
11-25	2072-2075	the	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-26	2076-2083	maximum	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-27	2084-2087	AAA	abstract[113]|event[114]|organization|abstract[116]	new[113]|giv[114]|giv|giv[116]	coref	12-7[122_0]
11-28	2088-2096	diameter	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-29	2097-2098	(	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-30	2099-2100	[	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-31	2101-2102	7	abstract[113]|event[114]|abstract[116]|abstract	new[113]|giv[114]|giv[116]|new	_	_
11-32	2103-2104	]	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-33	2105-2108	and	abstract[113]|event[114]|abstract[116]	new[113]|giv[114]|giv[116]	_	_
11-34	2109-2118	reference	abstract[113]|event[114]|abstract[116]|abstract[118]	new[113]|giv[114]|giv[116]|new[118]	_	_
11-35	2119-2126	therein	abstract[113]|event[114]|abstract[116]|abstract[118]	new[113]|giv[114]|giv[116]|new[118]	_	_
11-36	2127-2128	,	_	_	_	_
11-37	2129-2130	)	_	_	_	_
11-38	2131-2132	.	_	_	_	_

#Text=The blood flow patterns associated with an AAA have been widely investigated via numerical methods .
12-1	2133-2136	The	abstract[121]	new[121]	_	_
12-2	2137-2142	blood	substance|abstract[121]	new|new[121]	coref	14-19[132_0]
12-3	2143-2147	flow	abstract|abstract[121]	new|new[121]	coref	14-7
12-4	2148-2156	patterns	abstract[121]	new[121]	_	_
12-5	2157-2167	associated	_	_	_	_
12-6	2168-2172	with	_	_	_	_
12-7	2173-2175	an	organization[122]	giv[122]	coref	15-33[159_122]
12-8	2176-2179	AAA	organization[122]	giv[122]	_	_
12-9	2180-2184	have	_	_	_	_
12-10	2185-2189	been	_	_	_	_
12-11	2190-2196	widely	_	_	_	_
12-12	2197-2209	investigated	_	_	_	_
12-13	2210-2213	via	_	_	_	_
12-14	2214-2223	numerical	abstract[123]	new[123]	_	_
12-15	2224-2231	methods	abstract[123]	new[123]	_	_
12-16	2232-2233	.	_	_	_	_

#Text=The models may consider different levels of complexity .
13-1	2234-2237	The	abstract[124]	new[124]	coref	22-37[241_124]
13-2	2238-2244	models	abstract[124]	new[124]	_	_
13-3	2245-2248	may	_	_	_	_
13-4	2249-2257	consider	_	_	_	_
13-5	2258-2267	different	abstract[125]	new[125]	_	_
13-6	2268-2274	levels	abstract[125]	new[125]	_	_
13-7	2275-2277	of	abstract[125]	new[125]	_	_
13-8	2278-2288	complexity	abstract[125]|abstract	new[125]|new	coref	22-34
13-9	2289-2290	.	_	_	_	_

#Text=In , the authors investigated the flow field in an axisymmetric two-aneurysm model with rigid walls and assuming the blood as a Newtonian incompressible fluid in stationary conditions and in a range of Reynolds numbers 10 < Re < 2265 ; the flow was characterized in terms of the distributions of wall pressure , wall shear stress ( WSS ) and wall shear stress gradient ( WSSG ) .
14-1	2291-2293	In	_	_	_	_
14-2	2294-2295	,	_	_	_	_
14-3	2296-2299	the	person[127]	new[127]	coref	18-3[194_127]
14-4	2300-2307	authors	person[127]	new[127]	_	_
14-5	2308-2320	investigated	_	_	_	_
14-6	2321-2324	the	abstract[129]	new[129]	coref	26-5[0_129]
14-7	2325-2329	flow	abstract|abstract[129]	giv|new[129]	coref	14-42[138_0]
14-8	2330-2335	field	abstract[129]	new[129]	_	_
14-9	2336-2338	in	abstract[129]	new[129]	_	_
14-10	2339-2341	an	abstract[129]|abstract[130]	new[129]|new[130]	coref	23-20[250_130]
14-11	2342-2354	axisymmetric	abstract[129]|abstract[130]	new[129]|new[130]	_	_
14-12	2355-2367	two-aneurysm	abstract[129]|abstract[130]	new[129]|new[130]	_	_
14-13	2368-2373	model	abstract[129]|abstract[130]	new[129]|new[130]	_	_
14-14	2374-2378	with	abstract[129]|abstract[130]	new[129]|new[130]	_	_
14-15	2379-2384	rigid	abstract[129]|abstract[130]|object[131]	new[129]|new[130]|new[131]	coref	15-37[160_131]
14-16	2385-2390	walls	abstract[129]|abstract[130]|object[131]	new[129]|new[130]|new[131]	_	_
14-17	2391-2394	and	_	_	_	_
14-18	2395-2403	assuming	_	_	_	_
14-19	2404-2407	the	substance[132]	giv[132]	coref	21-19[0_132]
14-20	2408-2413	blood	substance[132]	giv[132]	_	_
14-21	2414-2416	as	substance[132]	giv[132]	_	_
14-22	2417-2418	a	substance[132]	giv[132]	_	_
14-23	2419-2428	Newtonian	substance[132]|person	giv[132]|new	_	_
14-24	2429-2443	incompressible	substance[132]	giv[132]	_	_
14-25	2444-2449	fluid	substance[132]	giv[132]	_	_
14-26	2450-2452	in	substance[132]	giv[132]	_	_
14-27	2453-2463	stationary	substance[132]|abstract[134]	giv[132]|new[134]	coref	15-54[165_134]
14-28	2464-2474	conditions	substance[132]|abstract[134]	giv[132]|new[134]	_	_
14-29	2475-2478	and	_	_	_	_
14-30	2479-2481	in	_	_	_	_
14-31	2482-2483	a	_	_	_	_
14-32	2484-2489	range	_	_	_	_
14-33	2490-2492	of	_	_	_	_
14-34	2493-2501	Reynolds	person|abstract[136]	new|new[136]	_	_
14-35	2502-2509	numbers	abstract[136]	new[136]	_	_
14-36	2510-2512	10	abstract[136]	new[136]	_	_
14-37	2513-2514	<	_	_	_	_
14-38	2515-2517	Re	abstract	new	coref	15-46
14-39	2518-2519	<	_	_	_	_
14-40	2520-2524	2265	_	_	_	_
14-41	2525-2526	;	_	_	_	_
14-42	2527-2530	the	abstract[138]	giv[138]	coref	15-26[155_138]
14-43	2531-2535	flow	abstract[138]	giv[138]	_	_
14-44	2536-2539	was	_	_	_	_
14-45	2540-2553	characterized	_	_	_	_
14-46	2554-2556	in	_	_	_	_
14-47	2557-2562	terms	_	_	_	_
14-48	2563-2565	of	_	_	_	_
14-49	2566-2569	the	abstract[139]	new[139]	coref	24-10[259_139]
14-50	2570-2583	distributions	abstract[139]	new[139]	_	_
14-51	2584-2586	of	abstract[139]	new[139]	_	_
14-52	2587-2591	wall	abstract[139]|object|abstract[141]	new[139]|giv|giv[141]	coref|coref	14-55|14-55
14-53	2592-2600	pressure	abstract[139]|abstract[141]	new[139]|giv[141]	_	_
14-54	2601-2602	,	abstract[139]	new[139]	_	_
14-55	2603-2607	wall	abstract[139]|object|abstract[144]	new[139]|giv|giv[144]	coref|coref|coref|coref	14-59[0_144]|14-62|14-59[0_144]|14-62
14-56	2608-2613	shear	abstract[139]|place|abstract[144]	new[139]|giv|giv[144]	coref	14-63
14-57	2614-2620	stress	abstract[139]|abstract[144]	new[139]|giv[144]	_	_
14-58	2621-2622	(	abstract[139]	new[139]	_	_
14-59	2623-2626	WSS	abstract[139]|abstract	new[139]|giv	coref	14-64
14-60	2627-2628	)	abstract[139]	new[139]	_	_
14-61	2629-2632	and	abstract[139]	new[139]	_	_
14-62	2633-2637	wall	abstract[139]|object|abstract[149]	new[139]|giv|giv[149]	coref|coref|coref|coref	14-67[0_149]|17-31[191_0]|14-67[0_149]|17-31[191_0]
14-63	2638-2643	shear	abstract[139]|abstract|abstract[149]	new[139]|giv|giv[149]	_	_
14-64	2644-2650	stress	abstract[139]|abstract|abstract[149]	new[139]|giv|giv[149]	coref	18-23[203_0]
14-65	2651-2659	gradient	abstract[139]|abstract[149]	new[139]|giv[149]	_	_
14-66	2660-2661	(	_	_	_	_
14-67	2662-2666	WSSG	abstract	giv	coref	24-10
14-68	2667-2668	)	_	_	_	_
14-69	2669-2670	.	_	_	_	_

#Text=In the role of the shape and of the geometric features , as asymmetry and iliac bifurcation , are investigated ; in the correlation between blood flow and platelet deposition mechanisms in an axisymmetric aneurysm with rigid walls was investigated in the range 300 < Re < 3600 , i. e. , under both laminar and turbulent flow conditions .
15-1	2671-2673	In	_	_	_	_
15-2	2674-2677	the	abstract[151]	new[151]	_	_
15-3	2678-2682	role	abstract[151]	new[151]	_	_
15-4	2683-2685	of	abstract[151]	new[151]	_	_
15-5	2686-2689	the	abstract[151]|abstract[152]	new[151]|new[152]	_	_
15-6	2690-2695	shape	abstract[151]|abstract[152]	new[151]|new[152]	_	_
15-7	2696-2699	and	_	_	_	_
15-8	2700-2702	of	_	_	_	_
15-9	2703-2706	the	_	_	_	_
15-10	2707-2716	geometric	_	_	_	_
15-11	2717-2725	features	_	_	_	_
15-12	2726-2727	,	_	_	_	_
15-13	2728-2730	as	_	_	_	_
15-14	2731-2740	asymmetry	_	_	_	_
15-15	2741-2744	and	_	_	_	_
15-16	2745-2750	iliac	person	new	_	_
15-17	2751-2762	bifurcation	_	_	_	_
15-18	2763-2764	,	_	_	_	_
15-19	2765-2768	are	_	_	_	_
15-20	2769-2781	investigated	_	_	_	_
15-21	2782-2783	;	_	_	_	_
15-22	2784-2786	in	_	_	_	_
15-23	2787-2790	the	abstract[154]	new[154]	_	_
15-24	2791-2802	correlation	abstract[154]	new[154]	_	_
15-25	2803-2810	between	abstract[154]	new[154]	_	_
15-26	2811-2816	blood	abstract[154]|abstract[155]	new[154]|giv[155]	coref	15-58[0_155]
15-27	2817-2821	flow	abstract[154]|abstract[155]	new[154]|giv[155]	_	_
15-28	2822-2825	and	abstract[154]	new[154]	_	_
15-29	2826-2834	platelet	abstract[154]|substance|abstract[158]	new[154]|new|new[158]	coref|coref	16-35|16-35
15-30	2835-2845	deposition	abstract[154]|abstract|abstract[158]	new[154]|new|new[158]	coref	16-36
15-31	2846-2856	mechanisms	abstract[154]|abstract[158]	new[154]|new[158]	_	_
15-32	2857-2859	in	abstract[154]|abstract[158]	new[154]|new[158]	_	_
15-33	2860-2862	an	abstract[154]|abstract[158]|organization[159]	new[154]|new[158]|giv[159]	coref	17-38[193_159]
15-34	2863-2875	axisymmetric	abstract[154]|abstract[158]|organization[159]	new[154]|new[158]|giv[159]	_	_
15-35	2876-2884	aneurysm	abstract[154]|abstract[158]|organization[159]	new[154]|new[158]|giv[159]	_	_
15-36	2885-2889	with	abstract[154]|abstract[158]|organization[159]	new[154]|new[158]|giv[159]	_	_
15-37	2890-2895	rigid	abstract[154]|abstract[158]|organization[159]|object[160]	new[154]|new[158]|giv[159]|giv[160]	_	_
15-38	2896-2901	walls	abstract[154]|abstract[158]|organization[159]|object[160]	new[154]|new[158]|giv[159]|giv[160]	_	_
15-39	2902-2905	was	_	_	_	_
15-40	2906-2918	investigated	_	_	_	_
15-41	2919-2921	in	_	_	_	_
15-42	2922-2925	the	abstract[161]	new[161]	coref	24-48[269_161]
15-43	2926-2931	range	abstract[161]	new[161]	_	_
15-44	2932-2935	300	_	_	_	_
15-45	2936-2937	<	_	_	_	_
15-46	2938-2940	Re	person	giv	coref	24-52
15-47	2941-2942	<	_	_	_	_
15-48	2943-2947	3600	quantity	new	_	_
15-49	2948-2949	,	_	_	_	_
15-50	2950-2952	i.	_	_	_	_
15-51	2953-2955	e.	_	_	_	_
15-52	2956-2957	,	_	_	_	_
15-53	2958-2963	under	_	_	_	_
15-54	2964-2968	both	abstract[165]	giv[165]	coref	23-29[253_165]
15-55	2969-2976	laminar	abstract[165]	giv[165]	_	_
15-56	2977-2980	and	abstract[165]	giv[165]	_	_
15-57	2981-2990	turbulent	abstract[165]	giv[165]	_	_
15-58	2991-2995	flow	abstract|abstract[165]	giv|giv[165]	coref	16-25
15-59	2996-3006	conditions	abstract[165]	giv[165]	_	_
15-60	3007-3008	.	_	_	_	_

#Text=The numerical simulations performed using a computational fluid dynamics ( CFD ) package , were validated through digital particle image velocimetry ( PIV ) flow measurements that allowed correlating the flow pattern with the platelet deposition mechanism .
16-1	3009-3012	The	abstract[166]	new[166]	_	_
16-2	3013-3022	numerical	abstract[166]	new[166]	_	_
16-3	3023-3034	simulations	abstract[166]	new[166]	_	_
16-4	3035-3044	performed	_	_	_	_
16-5	3045-3050	using	_	_	_	_
16-6	3051-3052	a	abstract[168]	new[168]	appos	16-11[0_168]
16-7	3053-3066	computational	abstract[168]	new[168]	_	_
16-8	3067-3072	fluid	substance|abstract[168]	new|new[168]	coref	24-38
16-9	3073-3081	dynamics	abstract[168]	new[168]	_	_
16-10	3082-3083	(	_	_	_	_
16-11	3084-3087	CFD	abstract	giv	coref	24-36[266_0]
16-12	3088-3089	)	_	_	_	_
16-13	3090-3097	package	object	new	_	_
16-14	3098-3099	,	_	_	_	_
16-15	3100-3104	were	_	_	_	_
16-16	3105-3114	validated	_	_	_	_
16-17	3115-3122	through	_	_	_	_
16-18	3123-3130	digital	object[172]	new[172]	coref	23-12[247_172]
16-19	3131-3139	particle	object|object[172]	new|new[172]	coref	23-13
16-20	3140-3145	image	object[172]	new[172]	_	_
16-21	3146-3157	velocimetry	object	new	appos	16-23
16-22	3158-3159	(	_	_	_	_
16-23	3160-3163	PIV	object	giv	coref	23-12[248_0]
16-24	3164-3165	)	_	_	_	_
16-25	3166-3170	flow	abstract|abstract[176]	giv|new[176]	coref|coref|coref|coref	16-31|23-9[245_176]|16-31|23-9[245_176]
16-26	3171-3183	measurements	abstract[176]	new[176]	_	_
16-27	3184-3188	that	_	_	_	_
16-28	3189-3196	allowed	_	_	_	_
16-29	3197-3208	correlating	_	_	_	_
16-30	3209-3212	the	abstract[178]	new[178]	coref	24-3[256_178]
16-31	3213-3217	flow	abstract|abstract[178]	giv|new[178]	coref	21-18[228_0]
16-32	3218-3225	pattern	abstract[178]	new[178]	_	_
16-33	3226-3230	with	_	_	_	_
16-34	3231-3234	the	abstract[181]	new[181]	_	_
16-35	3235-3243	platelet	object|abstract[181]	giv|new[181]	_	_
16-36	3244-3254	deposition	abstract|abstract[181]	giv|new[181]	_	_
16-37	3255-3264	mechanism	abstract[181]	new[181]	_	_
16-38	3265-3266	.	_	_	_	_

#Text=As a matter of fact , intra-luminal thrombus ( ILT ) has been associated with an increased rupture risk as it impacts both the biochemical and the mechanical properties of the vessel ’s wall in correspondence of the aneurysm .
17-1	3267-3269	As	_	_	_	_
17-2	3270-3271	a	_	_	_	_
17-3	3272-3278	matter	_	_	_	_
17-4	3279-3281	of	_	_	_	_
17-5	3282-3286	fact	abstract	new	_	_
17-6	3287-3288	,	_	_	_	_
17-7	3289-3302	intra-luminal	abstract[183]	new[183]	appos	17-10[0_183]
17-8	3303-3311	thrombus	abstract[183]	new[183]	_	_
17-9	3312-3313	(	_	_	_	_
17-10	3314-3317	ILT	abstract	giv	coref	18-9
17-11	3318-3319	)	_	_	_	_
17-12	3320-3323	has	_	_	_	_
17-13	3324-3328	been	_	_	_	_
17-14	3329-3339	associated	_	_	_	_
17-15	3340-3344	with	_	_	_	_
17-16	3345-3347	an	abstract[186]	giv[186]	ana	17-21[0_186]
17-17	3348-3357	increased	abstract[186]	giv[186]	_	_
17-18	3358-3365	rupture	event|abstract[186]	giv|giv[186]	coref	18-17[200_0]
17-19	3366-3370	risk	abstract[186]	giv[186]	_	_
17-20	3371-3373	as	_	_	_	_
17-21	3374-3376	it	abstract	giv	_	_
17-22	3377-3384	impacts	_	_	_	_
17-23	3385-3389	both	abstract[188]	new[188]	_	_
17-24	3390-3393	the	abstract[188]	new[188]	_	_
17-25	3394-3405	biochemical	abstract[188]	new[188]	_	_
17-26	3406-3409	and	_	_	_	_
17-27	3410-3413	the	abstract[189]	new[189]	_	_
17-28	3414-3424	mechanical	abstract[189]	new[189]	_	_
17-29	3425-3435	properties	abstract[189]	new[189]	_	_
17-30	3436-3438	of	abstract[189]	new[189]	_	_
17-31	3439-3442	the	abstract[189]|object[191]	new[189]|giv[191]	coref	18-24[0_191]
17-32	3443-3449	vessel	abstract[189]|object[190]|object[191]	new[189]|giv[190]|giv[191]	_	_
17-33	3450-3452	’s	abstract[189]|object[190]|object[191]	new[189]|giv[190]|giv[191]	_	_
17-34	3453-3457	wall	abstract[189]|object[191]	new[189]|giv[191]	_	_
17-35	3458-3460	in	abstract[189]|object[191]	new[189]|giv[191]	_	_
17-36	3461-3475	correspondence	abstract[189]|object[191]|abstract[192]	new[189]|giv[191]|new[192]	_	_
17-37	3476-3478	of	abstract[189]|object[191]|abstract[192]	new[189]|giv[191]|new[192]	_	_
17-38	3479-3482	the	abstract[189]|object[191]|abstract[192]|organization[193]	new[189]|giv[191]|new[192]|giv[193]	coref	18-17[0_193]
17-39	3483-3491	aneurysm	abstract[189]|object[191]|abstract[192]|organization[193]	new[189]|giv[191]|new[192]|giv[193]	_	_
17-40	3492-3493	.	_	_	_	_

#Text=In , the authors found that both increased ILT thickness and percentage volume are associated with AAA rupture of small aneurysms with low wall stress .
18-1	3494-3496	In	_	_	_	_
18-2	3497-3498	,	_	_	_	_
18-3	3499-3502	the	person[194]	giv[194]	ana	20-20[0_194]
18-4	3503-3510	authors	person[194]	giv[194]	_	_
18-5	3511-3516	found	_	_	_	_
18-6	3517-3521	that	_	_	_	_
18-7	3522-3526	both	abstract[196]	new[196]	_	_
18-8	3527-3536	increased	abstract[196]	new[196]	_	_
18-9	3537-3540	ILT	quantity|abstract[196]	giv|new[196]	coref	19-5
18-10	3541-3550	thickness	abstract[196]	new[196]	_	_
18-11	3551-3554	and	_	_	_	_
18-12	3555-3565	percentage	abstract|quantity[198]	new|new[198]	_	_
18-13	3566-3572	volume	quantity[198]	new[198]	_	_
18-14	3573-3576	are	_	_	_	_
18-15	3577-3587	associated	_	_	_	_
18-16	3588-3592	with	_	_	_	_
18-17	3593-3596	AAA	organization|event[200]	giv|giv[200]	coref|coref|coref|coref	20-28|20-27[216_200]|20-28|20-27[216_200]
18-18	3597-3604	rupture	event[200]	giv[200]	_	_
18-19	3605-3607	of	event[200]	giv[200]	_	_
18-20	3608-3613	small	event[200]|object[201]	giv[200]|new[201]	coref	19-18[211_201]
18-21	3614-3623	aneurysms	event[200]|object[201]	giv[200]|new[201]	_	_
18-22	3624-3628	with	event[200]|object[201]	giv[200]|new[201]	_	_
18-23	3629-3632	low	event[200]|object[201]|abstract[203]	giv[200]|new[201]|giv[203]	coref	24-7[257_203]
18-24	3633-3637	wall	event[200]|object[201]|object|abstract[203]	giv[200]|new[201]|giv|giv[203]	coref	19-13
18-25	3638-3644	stress	event[200]|object[201]|abstract[203]	giv[200]|new[201]|giv[203]	_	_
18-26	3645-3646	.	_	_	_	_

#Text=In this sense , ILT may represent a surrogate marker of aortic wall degeneration and help in discerning high-risk aneurysms .
19-1	3647-3649	In	_	_	_	_
19-2	3650-3654	this	abstract[204]	new[204]	_	_
19-3	3655-3660	sense	abstract[204]	new[204]	_	_
19-4	3661-3662	,	_	_	_	_
19-5	3663-3666	ILT	abstract	giv	_	_
19-6	3667-3670	may	_	_	_	_
19-7	3671-3680	represent	_	_	_	_
19-8	3681-3682	a	abstract[207]	new[207]	_	_
19-9	3683-3692	surrogate	abstract|abstract[207]	new|new[207]	_	_
19-10	3693-3699	marker	abstract[207]	new[207]	_	_
19-11	3700-3702	of	abstract[207]	new[207]	_	_
19-12	3703-3709	aortic	abstract[207]|abstract|abstract[210]	new[207]|giv|new[210]	coref|coref	20-43|20-43
19-13	3710-3714	wall	abstract[207]|object|abstract[210]	new[207]|giv|new[210]	coref	20-36
19-14	3715-3727	degeneration	abstract[207]|abstract[210]	new[207]|new[210]	_	_
19-15	3728-3731	and	_	_	_	_
19-16	3732-3736	help	_	_	_	_
19-17	3737-3739	in	_	_	_	_
19-18	3740-3750	discerning	object[211]	giv[211]	_	_
19-19	3751-3760	high-risk	object[211]	giv[211]	_	_
19-20	3761-3770	aneurysms	object[211]	giv[211]	_	_
19-21	3771-3772	.	_	_	_	_

#Text=By analyzing a large set of ‘ small ’ , ‘ large ’ ruptured , and non-ruptured AAAs , they were also able to show that early AAA rupture is not a result of elevated wall stresses but the result of compromised aortic wall strength .
20-1	3773-3775	By	_	_	_	_
20-2	3776-3785	analyzing	_	_	_	_
20-3	3786-3787	a	abstract[212]	new[212]	_	_
20-4	3788-3793	large	abstract[212]	new[212]	_	_
20-5	3794-3797	set	abstract[212]	new[212]	_	_
20-6	3798-3800	of	abstract[212]	new[212]	_	_
20-7	3801-3802	‘	abstract[212]	new[212]	_	_
20-8	3803-3808	small	abstract[212]	new[212]	_	_
20-9	3809-3810	’	abstract[212]	new[212]	_	_
20-10	3811-3812	,	abstract[212]	new[212]	_	_
20-11	3813-3814	‘	abstract[212]|object[213]	new[212]|giv[213]	coref	21-22[229_213]
20-12	3815-3820	large	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-13	3821-3822	’	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-14	3823-3831	ruptured	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-15	3832-3833	,	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-16	3834-3837	and	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-17	3838-3850	non-ruptured	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-18	3851-3855	AAAs	abstract[212]|object[213]	new[212]|giv[213]	_	_
20-19	3856-3857	,	_	_	_	_
20-20	3858-3862	they	person	giv	coref	21-14[226_0]
20-21	3863-3867	were	_	_	_	_
20-22	3868-3872	also	_	_	_	_
20-23	3873-3877	able	_	_	_	_
20-24	3878-3880	to	_	_	_	_
20-25	3881-3885	show	_	_	_	_
20-26	3886-3890	that	_	_	_	_
20-27	3891-3896	early	event[216]	giv[216]	coref	21-30[0_216]
20-28	3897-3900	AAA	organization|event[216]	giv|giv[216]	coref	23-26[251_0]
20-29	3901-3908	rupture	event[216]	giv[216]	_	_
20-30	3909-3911	is	_	_	_	_
20-31	3912-3915	not	_	_	_	_
20-32	3916-3917	a	_	_	_	_
20-33	3918-3924	result	_	_	_	_
20-34	3925-3927	of	_	_	_	_
20-35	3928-3936	elevated	abstract[218]	new[218]	_	_
20-36	3937-3941	wall	object|abstract[218]	giv|new[218]	coref	20-44
20-37	3942-3950	stresses	abstract[218]	new[218]	_	_
20-38	3951-3954	but	_	_	_	_
20-39	3955-3958	the	abstract[219]	new[219]	_	_
20-40	3959-3965	result	abstract[219]	new[219]	_	_
20-41	3966-3968	of	abstract[219]	new[219]	_	_
20-42	3969-3980	compromised	abstract[219]|abstract[222]	new[219]|new[222]	_	_
20-43	3981-3987	aortic	abstract[219]|abstract|abstract[222]	new[219]|giv|new[222]	_	_
20-44	3988-3992	wall	abstract[219]|object|abstract[222]	new[219]|giv|new[222]	_	_
20-45	3993-4001	strength	abstract[219]|abstract[222]	new[219]|new[222]	_	_
20-46	4002-4003	.	_	_	_	_

#Text=Similar findings were obtained by Boyd et al. ; in this case , the authors numerically simulated the blood flow in ruptured AAAs to correlate local hemodynamic factors with rupture location .
21-1	4004-4011	Similar	abstract[223]	new[223]	_	_
21-2	4012-4020	findings	abstract[223]	new[223]	_	_
21-3	4021-4025	were	_	_	_	_
21-4	4026-4034	obtained	_	_	_	_
21-5	4035-4037	by	_	_	_	_
21-6	4038-4042	Boyd	person	new	_	_
21-7	4043-4045	et	_	_	_	_
21-8	4046-4049	al.	_	_	_	_
21-9	4050-4051	;	_	_	_	_
21-10	4052-4054	in	_	_	_	_
21-11	4055-4059	this	abstract[225]	new[225]	_	_
21-12	4060-4064	case	abstract[225]	new[225]	_	_
21-13	4065-4066	,	_	_	_	_
21-14	4067-4070	the	person[226]	giv[226]	ana	24-1[0_226]
21-15	4071-4078	authors	person[226]	giv[226]	_	_
21-16	4079-4090	numerically	_	_	_	_
21-17	4091-4100	simulated	_	_	_	_
21-18	4101-4104	the	abstract[228]	giv[228]	ana	22-3[0_228]
21-19	4105-4110	blood	substance|abstract[228]	giv|giv[228]	_	_
21-20	4111-4115	flow	abstract[228]	giv[228]	_	_
21-21	4116-4118	in	abstract[228]	giv[228]	_	_
21-22	4119-4127	ruptured	abstract[228]|object[229]	giv[228]|giv[229]	_	_
21-23	4128-4132	AAAs	abstract[228]|object[229]	giv[228]|giv[229]	_	_
21-24	4133-4135	to	_	_	_	_
21-25	4136-4145	correlate	_	_	_	_
21-26	4146-4151	local	abstract[230]	giv[230]	_	_
21-27	4152-4163	hemodynamic	abstract[230]	giv[230]	_	_
21-28	4164-4171	factors	abstract[230]	giv[230]	_	_
21-29	4172-4176	with	_	_	_	_
21-30	4177-4184	rupture	event|event[232]	giv|new[232]	_	_
21-31	4185-4193	location	event[232]	new[232]	_	_
21-32	4194-4195	.	_	_	_	_

#Text=Nevertheless , it has to be noticed that numerical study may lack of an experimental validation ; to this aim , in vitro modeling have been very useful in the characterization of the complexity implicit in cardiovascular models .
22-1	4196-4208	Nevertheless	_	_	_	_
22-2	4209-4210	,	_	_	_	_
22-3	4211-4213	it	abstract	giv	coref	23-9
22-4	4214-4217	has	_	_	_	_
22-5	4218-4220	to	_	_	_	_
22-6	4221-4223	be	_	_	_	_
22-7	4224-4231	noticed	_	_	_	_
22-8	4232-4236	that	_	_	_	_
22-9	4237-4246	numerical	abstract[234]	new[234]	_	_
22-10	4247-4252	study	abstract[234]	new[234]	_	_
22-11	4253-4256	may	_	_	_	_
22-12	4257-4261	lack	_	_	_	_
22-13	4262-4264	of	_	_	_	_
22-14	4265-4267	an	abstract[235]	new[235]	_	_
22-15	4268-4280	experimental	abstract[235]	new[235]	_	_
22-16	4281-4291	validation	abstract[235]	new[235]	_	_
22-17	4292-4293	;	_	_	_	_
22-18	4294-4296	to	_	_	_	_
22-19	4297-4301	this	event[236]	giv[236]	_	_
22-20	4302-4305	aim	event[236]	giv[236]	_	_
22-21	4306-4307	,	_	_	_	_
22-22	4308-4310	in	_	_	_	_
22-23	4311-4316	vitro	abstract[237]	new[237]	_	_
22-24	4317-4325	modeling	abstract[237]	new[237]	_	_
22-25	4326-4330	have	_	_	_	_
22-26	4331-4335	been	_	_	_	_
22-27	4336-4340	very	_	_	_	_
22-28	4341-4347	useful	_	_	_	_
22-29	4348-4350	in	_	_	_	_
22-30	4351-4354	the	abstract[238]	new[238]	_	_
22-31	4355-4371	characterization	abstract[238]	new[238]	_	_
22-32	4372-4374	of	abstract[238]	new[238]	_	_
22-33	4375-4378	the	abstract[238]	new[238]	_	_
22-34	4379-4389	complexity	abstract[238]|abstract	new[238]|giv	_	_
22-35	4390-4398	implicit	abstract[238]	new[238]	_	_
22-36	4399-4401	in	abstract[238]	new[238]	_	_
22-37	4402-4416	cardiovascular	abstract[238]|abstract|abstract[241]	new[238]|new|giv[241]	_	_
22-38	4417-4423	models	abstract[238]|abstract[241]	new[238]|giv[241]	_	_
22-39	4424-4425	.	_	_	_	_

#Text=In this context , Salsac et al. performed flow measurements using 2D particle image velocimetry ( PIV ) in a rigid and symmetric model of an AAA under pulsatile flow conditions .
23-1	4426-4428	In	_	_	_	_
23-2	4429-4433	this	abstract[242]	new[242]	_	_
23-3	4434-4441	context	abstract[242]	new[242]	_	_
23-4	4442-4443	,	_	_	_	_
23-5	4444-4450	Salsac	person	new	_	_
23-6	4451-4453	et	_	_	_	_
23-7	4454-4457	al.	_	_	_	_
23-8	4458-4467	performed	_	_	_	_
23-9	4468-4472	flow	abstract|abstract[245]	giv|giv[245]	coref|coref|coref|coref	23-30|24-44[268_245]|23-30|24-44[268_245]
23-10	4473-4485	measurements	abstract[245]	giv[245]	_	_
23-11	4486-4491	using	_	_	_	_
23-12	4492-4494	2D	object[247]|object[248]	giv[247]|giv[248]	appos|appos	23-17[0_248]|23-17[0_248]
23-13	4495-4503	particle	object|object[247]|object[248]	giv|giv[247]|giv[248]	_	_
23-14	4504-4509	image	object[247]|object[248]	giv[247]|giv[248]	_	_
23-15	4510-4521	velocimetry	object[248]	giv[248]	_	_
23-16	4522-4523	(	_	_	_	_
23-17	4524-4527	PIV	object	giv	coref	25-28
23-18	4528-4529	)	_	_	_	_
23-19	4530-4532	in	_	_	_	_
23-20	4533-4534	a	abstract[250]	giv[250]	_	_
23-21	4535-4540	rigid	abstract[250]	giv[250]	_	_
23-22	4541-4544	and	abstract[250]	giv[250]	_	_
23-23	4545-4554	symmetric	abstract[250]	giv[250]	_	_
23-24	4555-4560	model	abstract[250]	giv[250]	_	_
23-25	4561-4563	of	abstract[250]	giv[250]	_	_
23-26	4564-4566	an	abstract[250]|organization[251]	giv[250]|giv[251]	coref	25-15[274_251]
23-27	4567-4570	AAA	abstract[250]|organization[251]	giv[250]|giv[251]	_	_
23-28	4571-4576	under	abstract[250]|organization[251]	giv[250]|giv[251]	_	_
23-29	4577-4586	pulsatile	abstract[250]|organization[251]|abstract[253]	giv[250]|giv[251]|giv[253]	_	_
23-30	4587-4591	flow	abstract[250]|organization[251]|abstract|abstract[253]	giv[250]|giv[251]|giv|giv[253]	coref	24-4
23-31	4592-4602	conditions	abstract[250]|organization[251]|abstract[253]	giv[250]|giv[251]|giv[253]	_	_
23-32	4603-4604	.	_	_	_	_

#Text=They investigated the flow pattern and the WSS and WSSG distributions changing the geometric parameters systematically . Stamatopoulos et al. studied both steady and periodic flows in an axisymmetric model of a fusiform aneurism using both computational fluid dynamics ( CFD ) and 2D PIV measurements in the range 100 < Re < 700 .
24-1	4605-4609	They	person	giv	coref	25-3[271_0]
24-2	4610-4622	investigated	_	_	_	_
24-3	4623-4626	the	abstract[256]	giv[256]	_	_
24-4	4627-4631	flow	abstract|abstract[256]	giv|giv[256]	coref	25-11[273_0]
24-5	4632-4639	pattern	abstract[256]	giv[256]	_	_
24-6	4640-4643	and	_	_	_	_
24-7	4644-4647	the	abstract[257]	giv[257]	_	_
24-8	4648-4651	WSS	abstract[257]	giv[257]	_	_
24-9	4652-4655	and	_	_	_	_
24-10	4656-4660	WSSG	abstract|abstract[259]	giv|giv[259]	_	_
24-11	4661-4674	distributions	abstract[259]	giv[259]	_	_
24-12	4675-4683	changing	_	_	_	_
24-13	4684-4687	the	abstract[260]	new[260]	_	_
24-14	4688-4697	geometric	abstract[260]	new[260]	_	_
24-15	4698-4708	parameters	abstract[260]	new[260]	_	_
24-16	4709-4723	systematically	_	_	_	_
24-17	4724-4725	.	_	_	_	_
24-18	4726-4739	Stamatopoulos	person	new	_	_
24-19	4740-4742	et	_	_	_	_
24-20	4743-4746	al.	_	_	_	_
24-21	4747-4754	studied	_	_	_	_
24-22	4755-4759	both	abstract[262]	new[262]	_	_
24-23	4760-4766	steady	abstract[262]	new[262]	_	_
24-24	4767-4770	and	abstract[262]	new[262]	_	_
24-25	4771-4779	periodic	abstract[262]	new[262]	_	_
24-26	4780-4785	flows	abstract[262]	new[262]	_	_
24-27	4786-4788	in	abstract[262]	new[262]	_	_
24-28	4789-4791	an	abstract[262]|object[263]	new[262]|new[263]	_	_
24-29	4792-4804	axisymmetric	abstract[262]|object[263]	new[262]|new[263]	_	_
24-30	4805-4810	model	abstract[262]|object[263]	new[262]|new[263]	_	_
24-31	4811-4813	of	abstract[262]|object[263]	new[262]|new[263]	_	_
24-32	4814-4815	a	abstract[262]|object[263]|object[264]	new[262]|new[263]|new[264]	_	_
24-33	4816-4824	fusiform	abstract[262]|object[263]|object[264]	new[262]|new[263]|new[264]	_	_
24-34	4825-4833	aneurism	abstract[262]|object[263]|object[264]	new[262]|new[263]|new[264]	_	_
24-35	4834-4839	using	_	_	_	_
24-36	4840-4844	both	abstract[266]	giv[266]	coref	24-41[0_266]
24-37	4845-4858	computational	abstract[266]	giv[266]	_	_
24-38	4859-4864	fluid	substance|abstract[266]	giv|giv[266]	_	_
24-39	4865-4873	dynamics	abstract[266]	giv[266]	_	_
24-40	4874-4875	(	_	_	_	_
24-41	4876-4879	CFD	abstract	giv	_	_
24-42	4880-4881	)	_	_	_	_
24-43	4882-4885	and	_	_	_	_
24-44	4886-4888	2D	abstract[268]	giv[268]	_	_
24-45	4889-4892	PIV	abstract[268]	giv[268]	_	_
24-46	4893-4905	measurements	abstract[268]	giv[268]	_	_
24-47	4906-4908	in	abstract[268]	giv[268]	_	_
24-48	4909-4912	the	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
24-49	4913-4918	range	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
24-50	4919-4922	100	abstract[268]|abstract[269]	giv[268]|giv[269]	_	_
24-51	4923-4924	<	_	_	_	_
24-52	4925-4927	Re	quantity	giv	_	_
24-53	4928-4929	<	_	_	_	_
24-54	4930-4933	700	_	_	_	_
24-55	4934-4935	.	_	_	_	_

#Text=In , the authors considered a rigid diseased phantom emulating the pulsatile flow in an AAA with aorto-iliac bifurcation and stenosis and measured the flow using 2D PIV .
25-1	4936-4938	In	_	_	_	_
25-2	4939-4940	,	_	_	_	_
25-3	4941-4944	the	person[271]	giv[271]	ana	26-1[0_271]
25-4	4945-4952	authors	person[271]	giv[271]	_	_
25-5	4953-4963	considered	_	_	_	_
25-6	4964-4965	a	person[272]	new[272]	_	_
25-7	4966-4971	rigid	person[272]	new[272]	_	_
25-8	4972-4980	diseased	person[272]	new[272]	_	_
25-9	4981-4988	phantom	person[272]	new[272]	_	_
25-10	4989-4998	emulating	_	_	_	_
25-11	4999-5002	the	abstract[273]	giv[273]	coref	25-24[277_273]
25-12	5003-5012	pulsatile	abstract[273]	giv[273]	_	_
25-13	5013-5017	flow	abstract[273]	giv[273]	_	_
25-14	5018-5020	in	abstract[273]	giv[273]	_	_
25-15	5021-5023	an	abstract[273]|organization[274]	giv[273]|giv[274]	_	_
25-16	5024-5027	AAA	abstract[273]|organization[274]	giv[273]|giv[274]	_	_
25-17	5028-5032	with	abstract[273]|organization[274]	giv[273]|giv[274]	_	_
25-18	5033-5044	aorto-iliac	abstract[273]|organization[274]|abstract[275]	giv[273]|giv[274]|new[275]	_	_
25-19	5045-5056	bifurcation	abstract[273]|organization[274]|abstract[275]	giv[273]|giv[274]|new[275]	_	_
25-20	5057-5060	and	abstract[273]|organization[274]	giv[273]|giv[274]	_	_
25-21	5061-5069	stenosis	abstract[273]|organization[274]|event	giv[273]|giv[274]|new	_	_
25-22	5070-5073	and	_	_	_	_
25-23	5074-5082	measured	_	_	_	_
25-24	5083-5086	the	abstract[277]	giv[277]	_	_
25-25	5087-5091	flow	abstract[277]	giv[277]	_	_
25-26	5092-5097	using	_	_	_	_
25-27	5098-5100	2D	abstract	new	_	_
25-28	5101-5104	PIV	abstract	giv	_	_
25-29	5105-5106	.	_	_	_	_

#Text=They investigated the vorticity field evolution , the vortex core trajectory , and the hemodynamics characteristics .
26-1	5107-5111	They	person	giv	_	_
26-2	5112-5124	investigated	_	_	_	_
26-3	5125-5128	the	abstract[283]	new[283]	_	_
26-4	5129-5138	vorticity	abstract|abstract[283]	new|new[283]	_	_
26-5	5139-5144	field	abstract|abstract[283]	giv|new[283]	_	_
26-6	5145-5154	evolution	abstract[283]	new[283]	_	_
26-7	5155-5156	,	_	_	_	_
26-8	5157-5160	the	abstract[285]	new[285]	_	_
26-9	5161-5167	vortex	abstract|abstract[285]	new|new[285]	_	_
26-10	5168-5172	core	abstract[285]	new[285]	_	_
26-11	5173-5183	trajectory	abstract[285]	new[285]	_	_
26-12	5184-5185	,	_	_	_	_
26-13	5186-5189	and	_	_	_	_
26-14	5190-5193	the	abstract[287]	new[287]	_	_
26-15	5194-5206	hemodynamics	abstract|abstract[287]	giv|new[287]	_	_
26-16	5207-5222	characteristics	abstract[287]	new[287]	_	_
26-17	5223-5224	.	_	_	_	_
